Allarity Therapeutics Presents New Phase 2 Clinical Data for Stenoparib/2X-121 Showing Landmark Median Overall Survival Has Now Surpassed 25 Months Nanotech Investing
Satellos Announces IND Submission to the U.S. FDA and Global Regulatory Filings to Advance a Phase 2 Clinical Trial of SAT-3247 in Children with Duchenne Muscular Dystrophy Nanotech Investing
Faraday Future Announces Strategic $41 Million Investment in Qualigen Therapeutics, Inc. for Crypto Business Through PIPE Transaction Nanotech Investing
Faraday Future Announces Strategic $41 Million Investment in Qualigen Therapeutics, Inc. f for Crypto Business Through PIPE Transaction Nanotech Investing
Nuvation Bio Receives Approval from Japan's Ministry of Health, Labour and Welfare for IBTROZITM for Patients with Advanced ROS1-positive Non-Small Cell Lung Cancer Nanotech Investing
Silo Pharma Announces Initial Investment in Ethereum and Solana under Cryptocurrency Treasury Strategy Nanotech Investing
Cullinan Therapeutics to Participate in Fireside Chat at the Stifel 2025 Virtual Immunology and Inflammation Forum Nanotech Investing
Silo Pharma Adds Japanese Patent to Expanding Global IP Portfolio for Licensed PTSD Drug Nanotech Investing
